PD-1 inhibitor (Nivolumab 360 mg Q3W IV ) starts at day 1, and continues until progression.
TATE treatment starts at day 8 for debulking up to 4 cycles. If escape lesion appears, two more TATE treatments can be given. Tirapazamine dose at 35 mg flat dose given before embolization.
a PD-1 immune check inhibitor
Other Name: OPDIVO
Combination Product: Trans-arterial tirapazamine embolization
Embolization with Lipiodol and Gelfoam
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
